Walgreens shares first Flu Index of flu season Keeping the deodorant category fresh is key to driving sales, profitsIn the deodorant category, aluminum is becoming taboo and the longtime ingredient is being avoided by a growing number of consumers, causing retailers and suppliers to change their product mix. AmerisourceBergen’s ThinkLive Summit focuses on innovation and patient access AmerisourceBergen's ThinkLive Summit showcased innovation and patient access, survey results, and awards. Biogen, Alkermes get FDA OK for Vumerity Biogen's and Alkermes' Vumerity is a new oral treatment option for relapsing forms of multiple sclerosis. Aurobindo’s generic Lodosyn gets FDA OK Carbidopa tablets had a market value of roughly $7.7 million for the 12 months ending August 2019, according to IQVIA. Lupin gets FDA nod for generic Depakote Divalproex sodium ER tablets, 250 mg and 500 mg had a market value of roughly $159 million, according to IQVIA June 2019 data. Alembic’s Aleor joint venture gets FDA green light for generic desonide Desonide ointment, 0.05%, had a market value of $13 million for the 12 months ended December 2018, according to IQVIA. NACDS supports DEA Drug Take Back Day National Prescription Drug Take Back Day helps to keep opioids out of the wrong hands and raises awareness of other resources that help keep patients, families, and communities safe. AAM launches #DoesntAddUp Ad campaign to bring down prescription drug costs The Association for Accessible Medicines' ad campaign to lower prescription drug prices is running across cable, digital platforms and print. Bryn partners with Aptra for nasal epinephrine treatment Aptar's Bidose device delivers two therapeutic doses of epinephrine, replacing the need to carry two epinephrine auto-injectors. First Previous 93 94 95 96 97 Next Last
